Bern-based LEM Surgical secures €23.6 million Series B to ready robotic system for FDA submission

Published on January 5, 2024

LEM Surgical, an innovative surgical robotics company headquartered in Bern, Switzerland, announced the successful completion of its Series B funding, securing €23.6 million. The strongly oversubscribed round reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This substantial funding boost is attributed to the enthusiastic participation of new investors from both the United States…

This content is for members only. Visit the site and log in/register to read.

The post Bern-based LEM Surgical secures €23.6 million Series B to ready robotic system for FDA submission appeared first on EU-Startups.